The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurology Clinical Trial Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Bone Marrow
1.2.3 Epidermis
1.2.4 Mesenchymal Stem Cells
1.2.5 Haematopoietic Stem Cells
1.2.6 Chondrocytes
1.3 Market by Application
1.3.1 Global Neurology Clinical Trial Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Neurodegenerative Disorders
1.3.3 Cardiovascular Disorders
1.3.4 Orthopedics
1.3.5 Wound Healing
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurology Clinical Trial Market Perspective (2018-2029)
2.2 Neurology Clinical Trial Growth Trends by Region
2.2.1 Global Neurology Clinical Trial Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Neurology Clinical Trial Historic Market Size by Region (2018-2023)
2.2.3 Neurology Clinical Trial Forecasted Market Size by Region (2024-2029)
2.3 Neurology Clinical Trial Market Dynamics
2.3.1 Neurology Clinical Trial Industry Trends
2.3.2 Neurology Clinical Trial Market Drivers
2.3.3 Neurology Clinical Trial Market Challenges
2.3.4 Neurology Clinical Trial Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurology Clinical Trial Players by Revenue
3.1.1 Global Top Neurology Clinical Trial Players by Revenue (2018-2023)
3.1.2 Global Neurology Clinical Trial Revenue Market Share by Players (2018-2023)
3.2 Global Neurology Clinical Trial Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neurology Clinical Trial Revenue
3.4 Global Neurology Clinical Trial Market Concentration Ratio
3.4.1 Global Neurology Clinical Trial Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurology Clinical Trial Revenue in 2022
3.5 Neurology Clinical Trial Key Players Head office and Area Served
3.6 Key Players Neurology Clinical Trial Product Solution and Service
3.7 Date of Enter into Neurology Clinical Trial Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurology Clinical Trial Breakdown Data by Type
4.1 Global Neurology Clinical Trial Historic Market Size by Type (2018-2023)
4.2 Global Neurology Clinical Trial Forecasted Market Size by Type (2024-2029)
5 Neurology Clinical Trial Breakdown Data by Application
5.1 Global Neurology Clinical Trial Historic Market Size by Application (2018-2023)
5.2 Global Neurology Clinical Trial Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Neurology Clinical Trial Market Size (2018-2029)
6.2 North America Neurology Clinical Trial Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Neurology Clinical Trial Market Size by Country (2018-2023)
6.4 North America Neurology Clinical Trial Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neurology Clinical Trial Market Size (2018-2029)
7.2 Europe Neurology Clinical Trial Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Neurology Clinical Trial Market Size by Country (2018-2023)
7.4 Europe Neurology Clinical Trial Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neurology Clinical Trial Market Size (2018-2029)
8.2 Asia-Pacific Neurology Clinical Trial Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Neurology Clinical Trial Market Size by Region (2018-2023)
8.4 Asia-Pacific Neurology Clinical Trial Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neurology Clinical Trial Market Size (2018-2029)
9.2 Latin America Neurology Clinical Trial Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Neurology Clinical Trial Market Size by Country (2018-2023)
9.4 Latin America Neurology Clinical Trial Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurology Clinical Trial Market Size (2018-2029)
10.2 Middle East & Africa Neurology Clinical Trial Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Neurology Clinical Trial Market Size by Country (2018-2023)
10.4 Middle East & Africa Neurology Clinical Trial Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BrainStorm Cell Therapeutics
11.1.1 BrainStorm Cell Therapeutics Company Detail
11.1.2 BrainStorm Cell Therapeutics Business Overview
11.1.3 BrainStorm Cell Therapeutics Neurology Clinical Trial Introduction
11.1.4 BrainStorm Cell Therapeutics Revenue in Neurology Clinical Trial Business (2018-2023)
11.1.5 BrainStorm Cell Therapeutics Recent Development
11.2 Opexa Therapeutics
11.2.1 Opexa Therapeutics Company Detail
11.2.2 Opexa Therapeutics Business Overview
11.2.3 Opexa Therapeutics Neurology Clinical Trial Introduction
11.2.4 Opexa Therapeutics Revenue in Neurology Clinical Trial Business (2018-2023)
11.2.5 Opexa Therapeutics Recent Development
11.3 Caladrius Biosciences
11.3.1 Caladrius Biosciences Company Detail
11.3.2 Caladrius Biosciences Business Overview
11.3.3 Caladrius Biosciences Neurology Clinical Trial Introduction
11.3.4 Caladrius Biosciences Revenue in Neurology Clinical Trial Business (2018-2023)
11.3.5 Caladrius Biosciences Recent Development
11.4 U.S. Stem Cell
11.4.1 U.S. Stem Cell Company Detail
11.4.2 U.S. Stem Cell Business Overview
11.4.3 U.S. Stem Cell Neurology Clinical Trial Introduction
11.4.4 U.S. Stem Cell Revenue in Neurology Clinical Trial Business (2018-2023)
11.4.5 U.S. Stem Cell Recent Development
11.5 Lonza
11.5.1 Lonza Company Detail
11.5.2 Lonza Business Overview
11.5.3 Lonza Neurology Clinical Trial Introduction
11.5.4 Lonza Revenue in Neurology Clinical Trial Business (2018-2023)
11.5.5 Lonza Recent Development
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Detail
11.6.2 Bristol Myers Squibb Business Overview
11.6.3 Bristol Myers Squibb Neurology Clinical Trial Introduction
11.6.4 Bristol Myers Squibb Revenue in Neurology Clinical Trial Business (2018-2023)
11.6.5 Bristol Myers Squibb Recent Development
11.7 Corning Incorporated
11.7.1 Corning Incorporated Company Detail
11.7.2 Corning Incorporated Business Overview
11.7.3 Corning Incorporated Neurology Clinical Trial Introduction
11.7.4 Corning Incorporated Revenue in Neurology Clinical Trial Business (2018-2023)
11.7.5 Corning Incorporated Recent Development
11.8 Vericel Corporation
11.8.1 Vericel Corporation Company Detail
11.8.2 Vericel Corporation Business Overview
11.8.3 Vericel Corporation Neurology Clinical Trial Introduction
11.8.4 Vericel Corporation Revenue in Neurology Clinical Trial Business (2018-2023)
11.8.5 Vericel Corporation Recent Development
11.9 Catalent
11.9.1 Catalent Company Detail
11.9.2 Catalent Business Overview
11.9.3 Catalent Neurology Clinical Trial Introduction
11.9.4 Catalent Revenue in Neurology Clinical Trial Business (2018-2023)
11.9.5 Catalent Recent Development
11.10 Lineage Cell Therapeutics
11.10.1 Lineage Cell Therapeutics Company Detail
11.10.2 Lineage Cell Therapeutics Business Overview
11.10.3 Lineage Cell Therapeutics Neurology Clinical Trial Introduction
11.10.4 Lineage Cell Therapeutics Revenue in Neurology Clinical Trial Business (2018-2023)
11.10.5 Lineage Cell Therapeutics Recent Development
11.11 Castle Creek Biosciences
11.11.1 Castle Creek Biosciences Company Detail
11.11.2 Castle Creek Biosciences Business Overview
11.11.3 Castle Creek Biosciences Neurology Clinical Trial Introduction
11.11.4 Castle Creek Biosciences Revenue in Neurology Clinical Trial Business (2018-2023)
11.11.5 Castle Creek Biosciences Recent Development
11.12 Sangamo Therapeutics
11.12.1 Sangamo Therapeutics Company Detail
11.12.2 Sangamo Therapeutics Business Overview
11.12.3 Sangamo Therapeutics Neurology Clinical Trial Introduction
11.12.4 Sangamo Therapeutics Revenue in Neurology Clinical Trial Business (2018-2023)
11.12.5 Sangamo Therapeutics Recent Development
11.13 Novartis
11.13.1 Novartis Company Detail
11.13.2 Novartis Business Overview
11.13.3 Novartis Neurology Clinical Trial Introduction
11.13.4 Novartis Revenue in Neurology Clinical Trial Business (2018-2023)
11.13.5 Novartis Recent Development
11.14 Holostem Terapie Avanzate S.R.L
11.14.1 Holostem Terapie Avanzate S.R.L Company Detail
11.14.2 Holostem Terapie Avanzate S.R.L Business Overview
11.14.3 Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Introduction
11.14.4 Holostem Terapie Avanzate S.R.L Revenue in Neurology Clinical Trial Business (2018-2023)
11.14.5 Holostem Terapie Avanzate S.R.L Recent Development
11.15 Pharmicell
11.15.1 Pharmicell Company Detail
11.15.2 Pharmicell Business Overview
11.15.3 Pharmicell Neurology Clinical Trial Introduction
11.15.4 Pharmicell Revenue in Neurology Clinical Trial Business (2018-2023)
11.15.5 Pharmicell Recent Development
11.16 Tego Science
11.16.1 Tego Science Company Detail
11.16.2 Tego Science Business Overview
11.16.3 Tego Science Neurology Clinical Trial Introduction
11.16.4 Tego Science Revenue in Neurology Clinical Trial Business (2018-2023)
11.16.5 Tego Science Recent Development
11.17 Autolus therapeutics
11.17.1 Autolus therapeutics Company Detail
11.17.2 Autolus therapeutics Business Overview
11.17.3 Autolus therapeutics Neurology Clinical Trial Introduction
11.17.4 Autolus therapeutics Revenue in Neurology Clinical Trial Business (2018-2023)
11.17.5 Autolus therapeutics Recent Development
11.18 Bayer AG
11.18.1 Bayer AG Company Detail
11.18.2 Bayer AG Business Overview
11.18.3 Bayer AG Neurology Clinical Trial Introduction
11.18.4 Bayer AG Revenue in Neurology Clinical Trial Business (2018-2023)
11.18.5 Bayer AG Recent Development
11.19 Sartorius AG
11.19.1 Sartorius AG Company Detail
11.19.2 Sartorius AG Business Overview
11.19.3 Sartorius AG Neurology Clinical Trial Introduction
11.19.4 Sartorius AG Revenue in Neurology Clinical Trial Business (2018-2023)
11.19.5 Sartorius AG Recent Development
11.20 Daiichi Sankyo
11.20.1 Daiichi Sankyo Company Detail
11.20.2 Daiichi Sankyo Business Overview
11.20.3 Daiichi Sankyo Neurology Clinical Trial Introduction
11.20.4 Daiichi Sankyo Revenue in Neurology Clinical Trial Business (2018-2023)
11.20.5 Daiichi Sankyo Recent Development
11.21 Takeda Pharmaceutical Company
11.21.1 Takeda Pharmaceutical Company Company Detail
11.21.2 Takeda Pharmaceutical Company Business Overview
11.21.3 Takeda Pharmaceutical Company Neurology Clinical Trial Introduction
11.21.4 Takeda Pharmaceutical Company Revenue in Neurology Clinical Trial Business (2018-2023)
11.21.5 Takeda Pharmaceutical Company Recent Development
11.22 Sumitomo Chemical Co
11.22.1 Sumitomo Chemical Co Company Detail
11.22.2 Sumitomo Chemical Co Business Overview
11.22.3 Sumitomo Chemical Co Neurology Clinical Trial Introduction
11.22.4 Sumitomo Chemical Co Revenue in Neurology Clinical Trial Business (2018-2023)
11.22.5 Sumitomo Chemical Co Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details